From April 2nd to April 5th, 2024, works related to the implementation of the new version of the Jagiellonian University Repository system will be carried out. It will not be possible to enter new information into the repository during this time. We apologize for any inconvenience.
Role of contrast enhancement and corrected attenuation values of renal tumors in predicting renal cell carcinoma (RCC) subtypes : protocol for a triphasic multi-slice computed tomography (CT) procedure
Role of contrast enhancement and corrected attenuation values of renal tumors in predicting renal cell carcinoma (RCC) subtypes : protocol for a triphasic multi-slice computed tomography (CT) procedure
Role of contrast enhancement and corrected attenuation values of renal tumors in predicting renal cell carcinoma (RCC) subtypes : protocol for a triphasic multi-slice computed tomography (CT) procedure
BACKGROUND: To distinguish RCC subtypes based on contrast enhancement features of CT images. MATERIAL AND METHODS: In total, 59 lesions from 57 patients were included. All patients underwent multi-slice CT imaging with a triphasic protocol, which included non-contrast, corticomedullary, nephrographic and urographic phases. Contrast enhancement features of renal masses were evaluated in terms of CT attenuation values (AV) and differences in contrast density; the aorta or renal parenchyma were evaluated based on corrected or relative values. RESULTS: Clear cell RCC (ccRCC) showed more intense contrast enhancement than other RCC subtypes. When differentiating ccRCC from other RCC subtypes, a cut-off AV of 86-89 HU, aorta-based corrected AV of 89-95 HU and renal parenchyma-based corrected AV of 87-95 HU showed a diagnostic accuracy of 81-86%, 86-88% and 74-78%, respectively, in the corticomedullary phase. Furthermore, a cutoff of 2.42-2.72 for the relative contrast enhancement ratio, a cutoff of 2.59-2.74 for the aorta-based corrected relative contrast enhancement ratio and a cutoff of 2.63-2.76 for the renal parenchyma-based attenuation ratio showed a diagnostic accuracy of 83-88%, 88-90% and 81%, respectively. CONCLUSIONS: The most reliable parameters for differentiating ccRCC from other RCC subtypes are aorta-based corrected AV and aorta-based corrected relative contrast enhancement values in the corticomedullary phase.
Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 3.0 Polska